Pliant Therapeutics, Inc. ( PLRX) - Key Metrics
PLRX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.36 | -$0.21 | -$0.21 |
| 2026Q1 | $0 | -$0.32 | -$0.31 | -$0.31 |
| 2025Q4 | $0 | -$0.38 | -$0.29 | -$0.29 |
| 2025Q3 | $0 | -$0.43 | -$0.34 | -$0.34 |
| 2025Q2 | $0 | -$0.71 | -$0.66 | -$0.66 |
PLRX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.79 |
| 2026Q1 | 0% | -0.98 |
| 2025Q4 | 0% | -0.80 |
| 2025Q3 | 0% | -0.86 |
| 2025Q2 | 0% | -0.41 |
PLRX
Price: $0.91
52 week price:
Earnings Per Share: -1.53 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.0 million
Market Capitalization: 61.3 million